Research ArticleLaboratory Studies
Fluorodeoxyglucose Uptake In Vitro: Aspects of Method and Effects of Treatment with Gemcitabine
Uwe Haberkorn, Iris Morr, Franz Oberdorfer, Matthias E. Bellemann, Johannes Blatter, Annette Altmann, Barbara Kahn and Gerhard van Kaick
Journal of Nuclear Medicine November 1994, 35 (11) 1842-1850;
Uwe Haberkorn
Iris Morr
Franz Oberdorfer
Matthias E. Bellemann
Johannes Blatter
Annette Altmann
Barbara Kahn


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Fluorodeoxyglucose Uptake In Vitro: Aspects of Method and Effects of Treatment with Gemcitabine
Uwe Haberkorn, Iris Morr, Franz Oberdorfer, Matthias E. Bellemann, Johannes Blatter, Annette Altmann, Barbara Kahn, Gerhard van Kaick
Journal of Nuclear Medicine Nov 1994, 35 (11) 1842-1850;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the Esophagus
- Treatment of Breast Tumor Cells In Vitro with the Mitochondrial Membrane Potential Dissipater Valinomycin Increases 18F-FDG Incorporation
- Positron Emission Tomography As an Imaging Biomarker
- Stunning and Its Effect on 3H-FDG Uptake and Key Gene Expression in Breast Cancer Cells Undergoing Chemotherapy
- Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
- Functional imaging for assessment of therapy
- 2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome
- Treatment of SW620 Cells with Tomudex and Oxaliplatin Induces Changes in 2-Deoxy-D-Glucose Incorporation Associated with Modifications in Glucose Transport
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose